Deepak Lab
@P_DeepakIBDLab
Followers
36
Following
76
Statuses
26
@WUGastro PI @P_DeepakIBDMD with focus on refractory IBD & Cardiometabolic disease across translational and interventional studies, novel imaging & RWE studies
Washington Univ, St Louis, MO
Joined August 2024
New Pub Alert‼️ @P_DeepakIBDLab @P_DeepakIBDMD
@AmerGastroAssn @AGA_GHAdvances Novel 💩 eukaryotic RNA-based (seRNA) reliably discriminates 🔥disease from remission & stratifies mild from moderate CD activity. Collaboration @GeneoscopyCo @EricaBarnell
0
2
2
RT @P_DeepakIBDMD: 🤩 to 🚀 new chapter as Co-Director @WashUMedIBD @WashUMedGastro @washumedicine. 🙏 to @CiorbaGI Director of the IBD Center…
0
10
0
@charlie_lees Yes super interesting and hopefully we (Louis Cohen, Andres and I) can unravel some of the mechanism, both biologically and metabolic/body comp parameters in next few years as we recruit our cohort.
0
1
2
RT @P_DeepakIBDMD: As we close down 2024 @WashUMedIBD @WashUMedGastro 👀 to 2025 In-person ONLY #GatewayGutClub featuring @AshwinMDIBD @MGH_…
0
2
0
RT @SunHoLee15: Thanks for highlighting our study @ReachMD! 👉Crohn’s Disease Care: Diving into the GEM Integrative Risk Score https://t.co…
0
7
0
RT @P_DeepakIBDMD: 🤩 to start 3-year study funded @HelmsleyTrust on 'GLP-1R Agonists to Promote Epithelial Healing in Crohn’s disease' with…
0
15
0
RT @P_DeepakIBDMD: Safety and Effectiveness of Glucagon-like Peptide-1 receptor agonists in #IBD: our experience @WashUMedIBD @WashUMedGast…
0
11
0
Our work on Single-Cell & Spatial Multi-omics in fistulizing perianal Crohn’s disease led @Siyan_Cao @P_DeepakIBDMD @WashUMedIBD @WashUMedGastro in collaboration with #KhaiNguyen @ColonnaLab now in preprint.
Single-Cell and Spatial Multi-omics Reveal Interferon Signaling in the Pathogenesis of Perianal Fistulizing Crohn's Disease #biorxiv_sysbio
0
5
10
RT @biorxiv_sysbio: Single-Cell and Spatial Multi-omics Reveal Interferon Signaling in the Pathogenesis of Perianal Fistulizing Crohn's Dis…
0
3
0
RT @AGA_Gastro: Study demonstrates the contribution of gut pathobionts in releasing OMVs that traverse the mucosal barrier and, thus, promo…
0
12
0
RT @JCC_IBD: GLP-1 analogs are associated with improved IBD outcomes! Gorelik et al. @Iris_Dotan
0
22
0
RT @ownyourcrohns: Thrilled to have been featured in @TIME alongside powerhouse #IBD advocates @GutlessGlamour @kimberlymhooks @nataliespar…
0
19
0
RT @ownyourcrohns: “My ostomy didn’t just save my life—it made me feel alive again” 💥 Happy #WorldOstomyDay!! I’m proud to work with IBD S…
0
17
0
RT @marilenharo: Joel Habener, Svetlana Mojsov and @lotte_bjerre, who contributed to the development of the anti-obesity drugs that are cha…
0
7
0
RT @tommasoparigi: 1 in 4 IBD in tertiary centers is difficult to treat. Time to focus research where is most needed. Find out more at: h…
0
4
0
@DDWMeeting Abstract Deadline later than usual On Dec 5th👇🏽@P_DeepakIBDMD
@BlaneyMD @AmCollegeGastro @AASLDtweets @AmerGastroAssn Our abstract submission deadline for #DDW2025 will be Dec. 5! Check out important dates here:
0
1
1
0
0
1